Dyslipidemia in Adults
Sign up for your free ClinicalKey trial today! Your first step in getting the right answers
when you need them.
Complications and Prognosis
Screening and Prevention
Encourage all patients with dyslipidemia to make healthy lifestyle changes to help reduce risk of atherosclerotic cardiovascular disease events r34
Pharmacologic therapy chosen to lower LDL-C levels is based on actual LDL-C levels and assessment of atherosclerotic cardiovascular disease and acute pancreatitis risk r1r35
Management of hypertriglyceridemia
Lifestyle management to reduce cardiovascular risk
Screen to identify candidates who may benefit from lifestyle or pharmacologic interventions (lipid-lowering therapy) aimed at reducing cardiovascular risk
American College of Cardiology/American Heart Association guideline recommends screening once every 4 to 6 years after age 20 years as part of overall cardiovascular risk assessment r1
American Association of Clinical Endocrinology guideline recommends the following: r27
Cookies are used by this site. To decline or learn more, visit our cookie notice.